Genentechs Tecentriq Atezolizumab as a FirstLine Monotherapy Helped Certain People With Advanced NonSmall Cell Lung Cancer Live Longer Compared With Chemotherapy

Data will be shared with health authorities globally including the U.S. Food and Drug Administration FDA and European Medicines Agency EMA Genentech a member of the Roche Group SIX RO ROG; OTCQX RHHBY today announced positive data from the Phase III IMpow...